Compendium of Cancer Genome Aberrations

PEDS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Paediatric Tumours (5th Edition) Content</big>
Line 17: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (HAEMATOLYMPHOID DISORDERS)
|
==== CHAPTER 2 (HAEMATOLYMPHOID DISORDERS) ====
|
|
----
----
Line 455: Line 458:
|
|
|-
|-
|CHAPTER 3 (CNS TUMOURS)
|
==== CHAPTER 3 (CNS TUMOURS) ====
|
|
----
----
Line 981: Line 985:
|
|
|-
|-
|CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS)
|
==== CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS) ====
|
|
----
----
Line 1,045: Line 1,050:
|
|
|-
|-
|CHAPTER 5 (EYE TUMOURS)
|
==== CHAPTER 5 (EYE TUMOURS) ====
|
|
----
----
Line 1,186: Line 1,192:
|
|
|-
|-
|CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS)
|
==== CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS) ====
|
|
----
----
Line 2,273: Line 2,280:
|
|
|-
|-
|CHAPTER 7 (GERM CELL TUMOURS)
|
==== CHAPTER 7 (GERM CELL TUMOURS) ====
|
|
----
----
Line 2,447: Line 2,455:
|
|
|-
|-
|CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS)
|
==== CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS) ====
|
|
----
----
Line 2,643: Line 2,652:
|
|
|-
|-
|CHAPTER 9 (FEMALE GENITAL TUMOURS)
|
==== CHAPTER 9 (FEMALE GENITAL TUMOURS) ====
|
|
----
----
Line 2,795: Line 2,805:
|
|
|-
|-
|CHAPTER 10 (BREAST TUMOURS)
|
==== CHAPTER 10 (BREAST TUMOURS) ====
|
|
----
----
Line 2,848: Line 2,859:
|
|
|-
|-
|CHAPTER 11 (DIGESTIVE SYSTEM TUMOUR)
|
==== CHAPTER 11 (DIGESTIVE SYSTEM TUMOURS) ====
|
|
----
----
Line 3,022: Line 3,034:
|
|
|-
|-
|CHAPTER 12 (ENDOCRINE TUMOURS)
|
==== CHAPTER 12 (ENDOCRINE TUMOURS) ====
|
|
----
----
Line 3,163: Line 3,176:
|
|
|-
|-
|CHAPTER 13 (HEAD AND NECK TUMOURS)
|
==== CHAPTER 13 (HEAD AND NECK TUMOURS) ====
|
|
----
----
Line 3,370: Line 3,384:
|
|
|-
|-
|CHAPTER 14 (THORACIC TUMOURS)
|
==== CHAPTER 14 (THORACIC TUMOURS) ====
|
|
----
----
Line 3,434: Line 3,449:
|
|
|-
|-
|CHAPTER 15 (SKIN TUMOURS)
|
==== CHAPTER 15 (SKIN TUMOURS) ====
|
|
----
----
Line 3,564: Line 3,580:
|
|
|-
|-
|CHAPTER 16 (GENETIC TUMOUR SYNDROMES)
|
==== CHAPTER 16 (GENETIC TUMOUR SYNDROMES) ====
|
|
----
----
Line 3,585: Line 3,602:
|-
|-
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|Disease
|
|
Line 3,595: Line 3,634:
|
|
|-
|-
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|[[PEDS5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
|Disease
|Disease
|
|
Line 3,606: Line 3,645:
|
|
|-
|-
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
|[[PEDS5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[PEDS5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
|Disease
|Disease
|
|
Line 3,641: Line 3,658:
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
Line 3,696: Line 3,713:
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
Line 3,729: Line 3,746:
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 3,762: Line 3,779:
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
Retrieved from "https://test.ccga.io/index.php/PEDS5:Volunteer_Assignments_and_Opportunities"